Epidemiology, risk factors, and lifestyle modifications for gout

Arthritis Research and Therapy

Volumn 8, Issue SUPPL. 1, 2006, Pages

  Saag, Kenneth G ^a   Choi, Hyon ^b,c  

^a The University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIINFECTIVE AGENT; ASCORBIC ACID; AZATHIOPRINE; CYCLOSPORIN; DIURETIC AGENT; DOCOSAHEXAENOIC ACID; ESTROGEN; ETHAMBUTOL; ICOSAPENTAENOIC ACID; IMMUNOSUPPRESSIVE AGENT; KETOCONAZOLE; LOSARTAN; OMEGA 3 FATTY ACID; PENTAMIDINE; PREDNISONE; PURINE; TACROLIMUS; THIAZIDE DIURETIC AGENT; URATE; URIC ACID;

AGE DISTRIBUTION; ALCOHOL CONSUMPTION; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; DIETARY INTAKE; DISEASE ASSOCIATION; DISEASE COURSE; DRUG DOSE REGIMEN; DRUG POTENTIATION; EPIDEMIOLOGICAL DATA; FEMALE; GOUT; GRAFT FAILURE; HUMAN; HYPERTENSION; HYPERURICEMIA; LIFESTYLE; LONGEVITY; LOW DRUG DOSE; MALE; MEDICAL CARE; METABOLIC SYNDROME X; OBESITY; PREVALENCE; REVIEW; RISK FACTOR; SEX RATIO; UNITED STATES; URIC ACID BLOOD LEVEL; AGE; AGING; ALCOHOLIC BEVERAGE; DAIRY PRODUCT; DIET RESTRICTION; DRUG DOSE COMPARISON; DRUG MEGADOSE; HEALTH CARE QUALITY; INCIDENCE; INDUSTRIALIZATION; LIFESTYLE MODIFICATION; PROTEIN DIET; WEIGHT REDUCTION; AGED; DRINKING BEHAVIOR; KIDNEY TRANSPLANTATION; MIDDLE AGED;

AGED; ALCOHOL DRINKING; FEMALE; GOUT; HUMANS; HYPERURICEMIA; INCIDENCE; KIDNEY TRANSPLANTATION; LIFE STYLE; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; UNITED STATES;

EID: 33745230455     PISSN: 14786354     EISSN: None     Source Type: Journal    
DOI: 10.1186/ar1907     Document Type: Review

References (62)

1. Campion E, Glynn R, DeLabry L: Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study. Am J Med 1987, 82:421-426.
2. Roubenoff R, Klag M, Mead L, Liang K, Seidler A, Hochberg M: Incidence and risk factors for gout in white men. JAMA 1991, 266:3004-3007.
3. Hochberg M, Thomas J, Thomas D, Mead L, Levine D, Klag M: Racial differences in the incidence of gout: the role of hypertension. Arthritis Rheum 1995, 38:628-632.
4. Arromdee E, Michet C, Crowson C, O'Fallon M, Gabriel S: Epidemiology of gout: is the incidence rising? J Rheumatol 2002, 29:2403-2406.
5. Adams PF, Hendershot GE, Marano MA, Centers for Disease Control and Prevention/National Center for Health Statistics: Current estimates from the National Health Interview Survey, 1996. Vital Health Stat 1999, 10:1-203.
6. Harris CM, Lloyd DC, Lewis J: The prevalence and prophylaxis of gout in England. J Clin Epidemiol 1995, 48:1153-1158.
7. Mikuls T, Farrar J, Bilker W, Fernandes S, Saag K: Suboptimal physician adherence to quality indicators for the management of gout and asymptomatic hyperuricaemia: results from the UK General Practice Research Database (GPRD). Rheumatology 2005, 44:1038-1042.
8. Klemp P, Stansfield S, Castle B, Robertson M: Gout is on the increase in New Zealand. Ann Rheum Dis 1997, 56:22-26.
9. Prior I, Rose B: Uric acid, gout and public health in the South Pacific. NZ Med J 1966, 65:295-300.
10. Kim KY, Ralph Schumacher H, Hunsche E, Wertheimer AI, Kong SX: A literature review of the epidemiology and treatment of acute gout. Clin Ther 2003, 25:1593-1617.
11. O'Sullivan J: Gout in a New England town: a prevalence study in Sudbury, Massachusetts. Ann Rheum Dis 1972, 31:166-169.
12. American Heart Association: Heart Disease and Stroke Statistics, 2004 Update. Dallas: AHA; 2003.
13. Hajjar I, Kotchen TA: Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA 2003, 290:199-206.
14. Rathmann W, Funkhouser E, Dyer AR, Roseman JM: Relations of hyperuricemia with the various components of the insulin resistance syndrome in young black and white adults: The CARDIA study. Ann Epidemiol 1998, 8:250-261.
15. Choi H, Atkinson K, Karlson E, Curhan G: Obesity, weight change, hypertension, diuretic use, and risk of gout in men. Arch Intern Med 2005, 165:742-748.
16. Tykarski A: Evaluation of renal handling of uric acid in essential hypertension: hyperuricemia related to decreased urate secretion. Nephron 1991, 59:364-368.
17. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo LJ Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, et al.; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee: The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. JAMA 2003, 289: 2560-2572.
18. Kim C, Beckles GL. Cardiovascular disease risk reduction in the Behavioral Risk Factor Surveillance System. Am J Prev Med 2004, 27:1-7.
19. Caspi D, Lubart E, Graff E, Habot B, Yaron M, Segal R: The effect of mini-dose aspirin on renal function and uric acid handling in elderly patients. Arthritis Rheum 2000, 43:103-108.
20. Wallace K, Riedel A, Joseph-Ridge N, Wortmann R: Increasing Prevalence of gout and hyperuricemia over 10 years among older adults in a managed care population. J Rheumatol 2004, 31:1582-1587.
21. Mikkelsen W, Dodge H, Valkenburg H: The distribution of serum uric acid values in a population unselected as to gout or hyperuricemia, Tecumseh, Michigan 1959-1960. Am J Med 1965, 39:242-251.
22. Lin KC, Lin HY, Chou P: Community based epidemiological study on hyperuricemia and gout in Kin-Hu, Kinmen. J Rheumatol 2000, 27:1045-1050.
23. Yu TF, Gutman AB: Study of the paradoxical effects of salicylate in low, intermediate and high dosage on the renal mechanisms of excretion of urate in man. J Clin Invest 1959, 38: 1298-1313.
24. Burack DA, Griffith BP, Thompson ME, Kahl LE: Hyperuricemia and gout among heart transplant recipients receiving cyclosporine. Am J Med 1992, 92:141-146.
25. Abdelrahman M, Rafi A, Ghacha R, Youmbissi JT, Gayyum T, Karkar A: Hyperuricemia and gout in renal transplant recipients. Ren Fail 2002, 24:361-367.
26. Better OS: Tubular dysfunction following kidney transplantation. Nephron 1980, 25:209-213.
27. Baroletti S, Bencivenga GA, Gabardi S: Treating gout in Kidney transplant recipients. Prog Transplant 2004, 14:143-147.
28. Hollander AA, van Saase JL, Kootte AM, van Dorp WT, van Bockel HJ, van Es LA, van der Woude FJ: Beneficial effects of conversion from cyclosporin to azathloprine after kidney transplantation. Lancet 1995, 345:610-614.
29. Peeters P, Sennesael J: Low-back pain caused by spinal tophus: a complication of gout in a kidney transplant recipient. Nephrol Dial Transplant 1998, 13:3245-3247.
30. Lin HY, Rocher LL, McQuillan MA, Schmaltz S, Palella TD, Fox IH. Cyclosporin-induced hyperuricemia and gout. N Engl J Med 1989, 321:287-292.
31. Pilmore HL, Faire B, Dittmer I: Tacrolimus for the treatment of gout in renal transplantation: two case reports and review of the literature. Transplantation 2001, 72:1703-1705.
32. Choi H, Atkinson K, Karlson E, Willett W, Curhan G: Purine-rich foods, dairy and protein intake, and the risk of gout in men. N Engl J Med 2004, 350:1093-1103.
33. Choi H, Atkinson K, Karlson E, Willett W, Curhan G: Alcohol intake and risk of incident gout in men: a prospective study. Lancet. 2004, 363:1277-1281.
34. Choi H, Curhan G: Beer, liquor, and wine consumption and serum uric acid level: the Third National Health and Nutrition Examination Survey. Arthritis Rheum 2004, 51:1023-1029.
35. St-Onge MP, Keller KL, Heymsfield SB: Changes in childhood food consumption patterns: a cause for concern in light of increasing body weights. Am J Clin Nutr 2003, 78:1068-1073.
36. Dessein P, Shipton E, Stanwix A, Joffe B, Ramokgadi J: Beneficial effects of weight loss associated with moderate calorie/carbohydrate restriction, and increased proportional intake of protein and unsaturated fat on serum urate and lipoprotein levels in gout: a pilot study. Ann Rheum Dis 2000, 59:539-543.
37. Glynn RJ, Campion EW, Silbert JE: Trends in serum uric acid levels 1961-1980. Arthritis Rheum 1983, 26:87-93.
38. Yamashita S, Matsuzawa Y, Tokunaga K, Fujioka S, Tarui S: Studies on the impaired metabolism of uric acid in obese subjects: marked reduction of renal urate excretion and its improvement by a low-calorie diet. Int J Obes 1986, 10:255-64.
39. Bieber J, Terkeltaub R: On the brink of novel therapeutic options for an ancient disease. Arthritis Rheum 2004, 50:2400-2414.
40. Ford ES, Giles WH, Dietz WH: Prevalence of the metabolic syndrome among U.S. adults. Findings from the Third National Health and Nutrition Examination Survey. JAMA 2002, 287:356-359.
41. Meigs JB, Wilson PW, Nathan DM, D'Agostino Sr RB, Williams K, Haffner SM: Prevalence and characteristics of the metabolic syndrome in the San Antonio Head and Framingham Off-spring Studies. Diabetes 2003, 52:2160-2167.
42. Sanchez-Lozada LG, Tapia E, Avila-Casado C, Soto V, Franco M, Santamaria J, Nakagawa T, Rodriguez-Iturbe B, Johnson RJ, Herrera-Acosta J: Mild hyperuricemia induces glomerular hypertension in normal rats. Am J Physiol Renal Physiol 2002, 283:F1105-1110.
43. Culleton BF, Larson MG, Kannel WB, Levy D: Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med 1999, 131:7-13.
44. Fang J, Alderman M: Serum uric acid and cardiovascular mortality: NHANES I epidemiologic follow-up study, 1971-1992. JAMA 2000, 283:2404-2410.
45. Høieggen A, Alderman MH, Kjeldsen SE, Julius S, Devereux RB, De Faire U, Fyhrquist F, Ibsen H, Kristianson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H, Chen C, Dahlöf B, for the LIFE Study Group: The impact of serum uric acid on cardiovascular outcomes in the LIFE study. Kidney Int 2004, 65:1041-1049.
46. August P: Initial treatment of hypertension. N Engl J Med 2003, 348:610-617.
47. Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL: Harrison's Principles of Internal Medicine, 16th ed. New York: McGraw-Hill Professional Publishing; 2004.
48. Choi HK, Mount DB, Reginato AM: Pathogenesis of gout. Ann Intern Med 2005, 143:499-516.
49. Willett WC, Stampfer MJ: Rebuilding the food pyramid. Sci Am 2003, 288:64-71.
50. Griebsch A, Zollner N: Effect of ribomononucleotides given orally on uric acid production in man. Adv Exp Med Bial 1974, 41:443-449.
51. Coe FL, Moran E, Kavalich AG: The contribution of dietary purine over-consumption to hyperpuricosuria in calcium oxalate stone formers. J Chronic Dis. 1976, 29:793-800.
52. Emmerson BT: The management of gout. N Engl J Med 1996, 334:445-451.
53. Christiansen E, Schnider S, Palmvig B, Tauber-Lassen E, Pedersen O: Intake of a diet high in trans monounsaturated fatty acids or saturated fatty acids. Effects on postprandial insulinemia and glycemia in obese patients with NIDDM. Diabetes Care 1997, 20:881-887.
54. Feskens EJ, Kromhout D: Habitual dietary intake and glucose tolerance in euglycaemic men: the Zutphen Study. Int J Epidemiol 1990, 19:953-959.
55. Tate GA, Mandell BF, Karmali RA, Laposata M, Baker DG, Schumacher HR, Jr, Zurier RB: Suppression of monosodium urate crystal-induced acute inflammation by diets enriched with gamma-linolenic acid and eicosapentaenoic acid. Arthritis Rheum 1988, 31:1543-1551.
56. Choi HK, Curhan G: Dairy consumption and risk of incident gout in women: The Nurses Health Study [abstract]. Arthritis Rheum 2005, 52(suppl 9):S31-S41.
57. Choi HK: Diet, alcohol, and gout: how do we advise patients given recent developments? Curr Rheumatol Rep 2005, 7:220-226.
58. Mitch WE, Johnson MW, Kirshenbaum JM, Lopez RE: Effect of large oral doses of ascorbic acid on uric acid excretion by normal subjects. Clin Pharmacol Ther 1981, 29:318-321.
59. Berger L, Gerson CD, Yu TF: The effect of ascorbic acid on uric acid excretion with a commentary on the renal handling of ascorbic acid. Am J Med 1977, 62:71-76.
60. Sutton JL, Basu TK, Dickerson JW: Effect of large doses of ascorbic acid in man on some nitrogenous components of urine. Hum Nutr Appl Nutr 1983, 37:136-140.
61. Stein HB, Hasan A, Fox IH: Ascorbic acid-induced uricosuria. A consequency of megavitamin therapy. Ann Intern Med 1976, 84:385-388.
62. Huang HY, Appel LJ, Choi MJ, Gelber AC, Charleston J, Norkus EP, Miller ER III: The effects of vitamin C supplementation on serum concentrations of uric acid: results of a randomized, controlled trial. Arthritis Rheum 2005, 52:1843-1847.